Pharma shares witnessed buying demand for fourth consecutive trading sessions.
At 12:25 IST, the barometer index, the S&P BSE Sensex advanced 38.99 points or 0.05% to 85,759.37. The Nifty 50 index added 5.05 points or 0.02% to 26,220.60.
In the broader market, the S&P BSE Mid-Cap index shed 0.07% and the S&P BSE Small-Cap index fell 0.13%.
The market breadth was almost even. On the BSE,1,960 shares rose and 1,950 shares fell. A total of 219 shares were unchanged.
Derivatives:
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, fell 4.80% to 11.24. The Nifty 30 December 2025 futures were trading at 26,401.10, at a premium of 180.5 points as compared with the spot at 26,220.60.
The Nifty option chain for the 30 December 2025 expiry showed a maximum call OI of 60.1 lakh contracts at the 26,000 strike price. Maximum put OI of 73.5 lakh contracts was seen at 26,000 strike price.
Buzzing Index:
The Nifty Pharma index advanced 0.38% to 22,948.50. The index jumped 2.03% in the four consecutive trading sessions.
Laurus Labs (up 2.45%), Ipca Laboratories (up 2.06%), Ajanta Pharma (up 0.76%), Glenmark Pharmaceuticals (up 0.58%), Sun Pharmaceutical Industries (up 0.57%), Lupin (up 0.51%), Alkem Laboratories (up 0.49%), Zydus Lifesciences (up 0.34%), Abbott India (up 0.32%) and Biocon (up 0.29%) advanced.
Stocks in Spotlight:
Ashoka Buildcon declined 3.37% after National Highways Authority of India (NHAI) temporarily suspended the company from participating in ongoing/future bids for one month or until an expert committee completes its investigation.
Newgen Software Technologies rose 0.21%. The company has secured an international contract from a leading bank in Malaysia to provide end-to-end project management services for an enterprise content management (ECM) system.
SEPC declined 1.37%. The company said it has bagged an AED 35,000,000 (Rs 85 crore) contract through its UAE arm, SEPC FZE, for a strategic energy infrastructure upgrade project in the United Arab Emirates.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
